G. Steven Burrill to give featured presentation at Diabetes Summit 2013 (April 29-30 in Boston, MA)
G. Steven Burrill to present at Diabetes Summit 2013 (April 29-30 in Boston, MA)

Diabetes Summit 2013 brings together venture capitalists, industry experts and leaders from academic institutions to cover many current and relevant aspects of diabetes. The following companies will be represented Rhythm, NIH, Novo Nordisk, Johnson and Johnson, Astra Zeneca, Thermo Fisher, Merck, Mesoblast, Zafgen, Medpace, Mannkind, Metanomics, Boston University, Harvard, Arizona State, Tufts, etc.
GTC's Diabetes Summit 2013 will run concurrently on April 29-30 in Boston, MA with Stem Cell Summit 2013. These two Summits will provide delegates unmatched learning and networking opportunities in the following tracks, provided through our Summit Pass:
1) Stem Cell Research and Regenerative Medicine
4) Stem Cell Commercialization and Partnering
3) 6th Diabetes Drug Discovery
4) 3rd Diabetes Partnering and Deal-making
For more information, please visit www.gtcbio.com/diabetes
###
Categories: Biotech
Press Release Contact
Company Contact:
GTC
635 W. Foothill Blvd. Monrovia, CA 91016
Tel: (626) 256-6405
fax: (626) 466-4433
email: infogtcbio@gtcbio.com
Company Contact:
GTC
635 W. Foothill Blvd. Monrovia, CA 91016
Tel: (626) 256-6405
fax: (626) 466-4433
email: infogtcbio@gtcbio.com